Comparing the effects of mindfulness-based cognitive therapy and psychoeducational therapy on symptomatology and neurophysiological correlates of adult attention deficit hyperactivity disorder (ADHD)

Comparing the effects of mindfulness-based cognitive therapy and psychoeducational therapy on symptomatology and neurophysiological correlates of adult ADHD: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12722296

Enrollment

100

Registered

2012-07-31

Start date

2012-09-15

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult attention deficit hyperactivity disorder (ADHD) Mental and Behavioural Disorders Disturbance of activity and attention

Interventions

Intervention 1: Mindfulness-based group psychotherapy for adult ADHD Duration: 8 weekly meetings, lasting 2.5 hours each Intervention 2: Psychoeducative group psychoth

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Men and women 2. First language German or comparable level 3. At least 18 years old, at most 65 years old 4. Diagnosed with ADHD (through a doctor or psychologist) 5. Wender Utah Rating Scale (WURS)-Score of at least 30 6. Subject?s consent in written form 7. Unlimited legal competency

Exclusion criteria

Exclusion criteria: 1. Following diagnoses: schizophrenia, bipolar disorder, antisocial personality disorder, borderline personality disorder, pervasive developmental disorder/autism, Tourette syndrome, alcohol or drug addiction (misuse, abuse) 2. Suicidality or self-harm 3. Body-Mass Index under 19 4. Pregnancy (first trimester) 5. Metallic implants in body 6. Tattoos 7. Claustrophobia (ICD 10 F40.2) 8. Past or current presence of neurological disease: stroke, epilepsy, dementia 9. Current taking methylphenidate and/or other stimulants 10. Participation in other psychotherapy during the 3 months prior to study treatment 11. Evidence of below-average intelligence measured using the Multiple choice vocabulary intelligence test (Mehrfachwahl-Wortschatz-Intelligenztest) (MWT-B) 12. Patient incapable of acting under law

Design outcomes

Primary

Measure	Time frame
1. ADHD symptomatology, measured using Conners Adult ADHD Rating Scale-Observer [Inattention Scale (A) and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ADHD- Overall Symptoms (G)] in week 0, week 8, and month 8 2. Neurobiological correlates: activity in caudate nucleus measured using functional magnetic resonance imaging (fMRI) in week 0, week 8, and month 8	—

Secondary

Measure	Time frame
1. Severity of depression, measured using Beck Depression Inventory II in week 0, week 8, and month 8 2. General psychopathology, measured using Symptom Check List- 90- revised in week 0, week 8, and month 8 3. Quality of life, measured using the German version of Short-Form 36 questionnaire in week 0, week 8, and month 8 4. Mindfulness, measured using the Five-Facet Mindfulness Questionnaire in week 0, week 8, and month 8 5. Nicotine dependence, measured using Fagerström Nicotine Dependence Test in week 0, week 8, and month 8 6. Caffeine consumption, recorded through single item in blind external assessment in week 0, week 8, and month 8 7. Extent of behavioral addiction, recorded through single item in blind external assessment in week 0, week 8, and month 8	—

Measure

Time frame

1. Severity of depression, measured using Beck Depression Inventory II in week 0, week 8, and month 8 2. General psychopathology, measured using Symptom Check List- 90- revised in week 0, week 8, and month 8 3. Quality of life, measured using the German version of Short-Form 36 questionnaire in week 0, week 8, and month 8 4. Mindfulness, measured using the Five-Facet Mindfulness Questionnaire in week 0, week 8, and month 8 5. Nicotine dependence, measured using Fagerström Nicotine Dependence Test in week 0, week 8, and month 8 6. Caffeine consumption, recorded through single item in blind external assessment in week 0, week 8, and month 8 7. Extent of behavioral addiction, recorded through single item in blind external assessment in week 0, week 8, and month 8

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026